
Yedida Y Bogachkov
Science Writer at Parkinson's News Today
Articles
-
2 months ago |
copdnewstoday.com | Caroline Gainer |Lindsey Shapiro |Patricia Inacio |Yedida Y Bogachkov
Chronic obstructive pulmonary disease (COPD) makes it hard to breathe, and many of us with the disease know that breathing exercises can help. Still, a study published in October in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation suggested that a combined inspiratory (inhalation) and expiratory (exhalation) muscle strength training device can help strengthen the muscles that aid in breathing.
-
Jan 23, 2025 |
myastheniagravisnews.com | Margarida Maia |Shawna Barnes |Yedida Y Bogachkov |Steve Bryson
People who are genetically predisposed to myasthenia gravis (MG) are more likely to develop Graves’ disease and Hashimoto’s thyroiditis, two autoimmune diseases of the thyroid gland, according to a study in China. Researchers also found a genetic link in the opposite direction, where being genetically predisposed to Graves’ disease or autoimmune hypothyroidism — when the thyroid gland becomes underactive — increased the likelihood of developing MG.
-
Jan 22, 2025 |
cushingsdiseasenews.com | Patricia Inacio |Yedida Y Bogachkov |Marisa Wexler |Katherine Poinsatte
A 5-year-old boy with an inflammatory skin condition developed Cushing’s syndrome following a year of his parents’ use of a topical corticosteroid cream to treat his psoriasis, according to a new case study.
-
Jan 10, 2025 |
pulmonaryfibrosisnews.com | Lindsey Shapiro |Steve Bryson |Yedida Y Bogachkov |Andrea Lobo
Inhibiting the HIF2 protein — fully, hypoxia-inducible factor 2 — was found to ease scarring in a mouse model of lung injury and could be a promising therapeutic strategy for treating idiopathic pulmonary fibrosis (IPF), according to the results of new preclinical research. In the lab, a team of U.S. scientists identified that HIF signaling was overly active in abnormal airway cells from IPF patients.
-
Dec 4, 2024 |
rettsyndromenews.com | Steve Bryson |Andrea Lobo |Yedida Y Bogachkov |Marta Costa Figueiredo
A research team has identified Rett syndrome-specific molecules that regulate gene activity, called microRNAs, that are associated with the growth of patient-derived brain cells and may serve as biomarkers for monitoring Rett progression. Using 3D organoids that mimic the brain, the team identified these microRNA fingerprints within extracellular vesicles (EVs), tiny particles secreted by cells that carry various bioactive molecules, including miRNAs, to promote cell-to-cell communication.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →